Usman Nassim
- SEC CIK
- 0001206872
No open-market purchases or sales filed in the past year.
Current role at each company
- GYRE Gyre Therapeutics, Inc.Directoras of Jul 1, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Usman Nassim as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 (view filing) | Jun 28 | 3 days | Usman NassimDirector | SSale | −3.45K | $12.00 | −$41.4K | −67.8%1.64K after | 10b5-1 |
| May 2, 2024 (view filing) | May 1 | 1 day | Usman NassimDirector | SSale | −20.0K | $14.13 | −$282.6K | −92.4%1.64K after | 3 lots10b5-1 |
| Apr 3, 2024 (view filing) | Apr 1 | 2 days | Usman NassimDirector | SSale | −20.0K | $16.15 | −$323.0K | −92.4%1.64K after | 10b5-1 |
| Mar 19, 2024 (view filing) | Mar 15 | 4 days | Usman NassimDirector | SSale | −20.0K | $17.26 | −$345.2K | −92.4%1.64K after | 10b5-1 |
| Aug 10, 2022 (view filing)5:19 PM ET | Aug 9 | 1 day | Usman NassimPresident & CEO | PPurchase | +3.25K | $0.47 | +$1.53K | +15.3%24.5K after | |
| Feb 16, 2022 (view filing)8:13 PM ET | Feb 9 | 7 daysLate | Usman NassimPresident & CEO | PPurchase | +3.25K | $0.46 | +$1.50K | +18.0%21.3K after | |
| Aug 11, 2021 (view filing) | Aug 9 | 2 days | Usman NassimPresident & CEO | PPurchase | +867 | $3.62 | +$3.14K | +5.0%18.0K after |